Cocrystal Pharma, Inc. Business Finance Contracts & Agreements
65 Contracts & Agreements
- Assignment Agreements (1 contract)
- Equity Distribution Agreements (4)
- Guaranty Agreements (1)
- Note Agreements (9)
- Purchase Agreements (22)
- Registration Rights Agreements (1)
- Security Agreements (2)
- Share Agreements (1)
- Stock Agreements (6)
- Subscription Agreements (4)
- Underwriting Agreements (4)
- Warrant Agreements (10)
- Securities Purchase Agreement dated April 4, 2023 (Filed With SEC on April 10, 2023)
- Underwriting Agreement, dated as of May 4, 2021 by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 5, 2021)
- Amended and Restated Underwriting Agreement, dated as of August 26, 2020, by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 27, 2020)
- Description of Capital Stock (Filed With SEC on March 27, 2020)
- Form of Securities Purchase Agreement, dated March 9, 2020, by and between the Company and the Purchasers (Filed With SEC on March 13, 2020)
- Form of Securities Purchase Agreement, dated February 27, 2020, by and between the Company and the Purchasers (Filed With SEC on March 4, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on January 31, 2020)
- Amendment to the Amended and Restated Equity Distribution Agreement, dated October 2, 2019 (Filed With SEC on January 29, 2020)
- Underwriting Agreement, dated as of October 30, 2019, by and between Cocrystal Pharma, Inc. and Aegis Capital Corp (Filed With SEC on October 31, 2019)
- Amended and Restated Equity Distribution Agreement, dated October 30, 2019 (Filed With SEC on October 30, 2019)
- Amendment to Equity Distribution Agreement, dated March 20, 2019 (Filed With SEC on March 26, 2019)
- Securities Purchase Agreement, dated March 11, 2019 (Filed With SEC on March 11, 2019)
- Equity Distribution Agreement, dated July 19, 2018 (Filed With SEC on July 20, 2018)
- Form of Warrant (Filed With SEC on May 2, 2018)
- Underwriting Agreement, dated as of April 30, 2018, by and between Cocrystal Pharma, Inc. and A.G.P./Alliance Global Partners as representative of the several underwriters (Filed With SEC on May 2, 2018)
- Form of Convertible Note dated November 24, 2017 (Filed With SEC on December 1, 2017)
- Form of Securities Purchase Agreement dated November 24, 2017 (Filed With SEC on December 1, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 2, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 15, 2016)
- FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 26, 2015)
- COCRYSTAL DISCOVERY, INC. SHARE PURCHASE AGREEMENT (Filed With SEC on May 15, 2014)
- COMMON STOCK PURCHASE WARRANT BIOZONE PARMACEUTICALS, INC. (Filed With SEC on January 21, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 21, 2014)
- ASSET PURCHASE AGREEMENT by and among MUSCLEPHARM CORPORATION, BIOZONE LABORATORIES INC., and BIOZONE PHARMACEUTICALS, INC., BIOZONE LABORATORIES, INC., BAKER CUMMINS CORP. and... (Filed With SEC on November 13, 2013)
- COMMON STOCK PURCHASE WARRANT BIOZONE PARMACEUTICALS, INC. (Filed With SEC on October 31, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 31, 2013)
- BIOZONE PHARMACEUTICALS, INC. Warrant (Filed With SEC on August 30, 2013)
- BIOZONE PHARMACEUTICALS, INC. SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 30, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 30, 2013)
- WARRANT (Filed With SEC on April 18, 2013)
- SUBSCRIPTION AGREEMENT (Filed With SEC on April 18, 2013)
- GUARANTY AND SECURITY AGREEMENT THIS DOCUMENT CONTAINS A WAIVER OF TRIAL BY JURY (Filed With SEC on April 1, 2013)
- PURCHASE MONEY FINANCING RIDER (Filed With SEC on April 1, 2013)
- FACTORING AND SECURITY AGREEMENT (Filed With SEC on April 1, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 28, 2012)
- BIOZONE PHARMACEUTICALS, INC. Warrant (Filed With SEC on July 5, 2012)
- BIOZONE PHARMACEUTICALS, INC. 10% PROMISSORY NOTE (Filed With SEC on July 5, 2012)
- STOCK PURCHASE AGREEMENT (Filed With SEC on July 2, 2012)
- BIOZONE PHARMACEUTICALS, INC. 10% PROMISSORY NOTE (Filed With SEC on June 20, 2012)
- BIOZONE PHARMACEUTICALS, INC. 10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 24, 2012)